A JOOMLA51 TEMPLATE
Home
Press
WVAEPS News
AAO Journal
AAO Education
AAO News
Media
About
Who We Are
Bylaws
Board of Directors
Membership
Member Login
Advocacy
Issues
Find Your Legislator
Congressional Advocacy
Resources
What is an ophthalmologist?
Diabetic Retinopathy
Find an Eye MD
Conference
Contact
AAO News Archive
Deal struck to develop integrin antagonist treatment
New low-add multifocal IOLs yield higher patient satisfaction
Regeneron, Bayer to develop AMD combination therapy
FDA approves wide-field imaging system for newborns
Brain mapping may someday lead to vision-restoring therapies
FDA warns of loose safety seals on eye drops
Stem cells regrow human lens, corneal tissue
Preventing Negative Dysphotopsia
Details
October 13, 2015
Dr. Sam Masket developed an IOL to prevent negative dysphotopsia, the dark or grey arc-shaped shadow seen in the temporal field of vision following uncomplicated cataract surgery.
Read full article on AAO News
Powered by
Versicherungsvergleich
WVAEPS Members
Member Login
Username
Password
Show Password
Remember Me
Sign in with a passkey
Log in
Forgot Login?
Sign up
AAO News
Deal struck to develop integrin antagonist treatment
New low-add multifocal IOLs yield higher patient satisfaction
Regeneron, Bayer to develop AMD combination therapy
FDA approves wide-field imaging system for newborns
Brain mapping may someday lead to vision-restoring therapies
AAO Education
Diagnose This: Iris growth after cataract surgery
Diagnose This: Iris growth after cataract surgery
Diagnose This: Clinical finding associated with acute retinal necrosis?
Diagnose This: Relationship of diabetic retinopathy to glucose control
Diagnose This: When is PRK more appropriate than LASIK?